Delivery Order SPE2DE24D0013-SPE2D625F6QP1
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance completion targeted for September 16, 2025. The contract contains no set-aside designation and represents a...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The U.S. Defense Department's Medical Supply Chain division awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. (Sunnyvale, CA) on April 23, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated XPCOV2/FLU/RSV-10, carries an ultimate completion date of April 30, 2025, and involves no set-aside provisions. This delivery order represents procurement activity under Cepheid's existing indefinite...
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- The U.S. Defense Department's Medical Supply Chain division awarded a $17,280 firm fixed-price delivery order to Cepheid Inc. on August 27, 2025, with an ultimate completion date of September 4, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, a Sunnyvale, California-based manufacturer of advanced diagnostic systems and test kits, was selected without a set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded a $170,000 firm fixed-price delivery order to Cepheid Inc. on September 25, 2025, with an ultimate completion date of October 2, 2025. This contract (4569615285) is designated as XPCOV2/FLU/RSV-10, indicating it supports diagnostic testing for COVID-19, influenza, and respiratory syncytial virus. The award carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading...
- The Defense Department's Medical Supply Chain awarded a $17,280 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 3, 2025, with completion targeted for September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and procures diagnostic testing solutions, likely reagents and assays for COVID-19, influenza, and respiratory syncytial virus detection based on the contract...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F6QP1Delivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on July 14, 2025, with an ultimate completion date of July 21, 2025, is designated as XPCOV2/FLU/RSV-10, indicating it relates to diagnostic testing for COVID-19, influenza, and respiratory syncytial virus. The contract carries no set-aside designation and represents a small-value procurement consistent with Cepheid's established role as a primary supplier of molecular diagnostic systems and reagents to federal healthcare entities. This delivery order likely falls under one of Cepheid's existing indefinite delivery vehicle contracts with the Veterans Administration, which hold combined values exceeding $35 million and provide continuous procurement of molecular diagnostic testing systems and assays through 2030. Cepheid's federal contracting history demonstrates consistent delivery of GeneXpert diagnostic systems, test kits, and related reagents across multiple federal agencies including the Department of Veterans Affairs and Defense Logistics Agency. The company's expertise in point-of-care diagnostic technologies and established infrastructure for federal procurement positions it as a qualified provider for the Medical Supply Chain's infectious disease testing requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 7/14/25 |